Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
Stocks
UK
LSE
Aston Martin Np (AMLN)
Aston Martin Np (AMLN) News

AMLN

Aston Martin Np (AMLN)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AMLN

<< Previous 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 Next >>

Date	Time	Source	Headline	Symbol	Company
04/20/2009	8:00AM	Edgar (US Regulatory)	Proxy Statment - Contested Solicitations (definitive) (DEFC14A)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/17/2009	5:15PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/16/2009	5:10PM	Dow Jones News	Amylin Pharma 1Q Loss Narrows; Co Reiterates Focus On Byetta	NASDAQ:AMLN	Amylin Pharmaceuticals Inc.
04/16/2009	4:35PM	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/16/2009	4:33PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/16/2009	4:05PM	PR Newswire (US)	Amylin Pharmaceuticals Reports First Quarter Financial Results	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/15/2009	5:15PM	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/15/2009	5:12PM	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/15/2009	5:11PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/15/2009	5:11PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/15/2009	3:03PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/15/2009	3:02PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/15/2009	10:45AM	PR Newswire (US)	Letter From Carl Icahn to Amylin Pharmaceutical, Inc.	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/13/2009	8:01AM	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (PRER14A)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/10/2009	12:36PM	Dow Jones News	UPDATE:Amylin Co-Founder Resigns From Board Amid Proxy Fight	NASDAQ:AMLN	Amylin Pharmaceuticals Inc.
04/10/2009	10:46AM	Dow Jones News	Amylin Co-Founder Resigns From Board Amid Proxy Fight	NASDAQ:AMLN	Amylin Pharmaceuticals Inc.
04/09/2009	5:28PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/09/2009	5:02PM	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/09/2009	5:01PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/09/2009	4:15PM	PR Newswire (US)	Amylin Pharmaceuticals to Webcast First Quarter Results	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/06/2009	3:13PM	Dow Jones News	Amylin Tries To Distance Itself From Novo Nordisk Drug	NASDAQ:AMLN	Amylin Pharmaceuticals Inc.
04/03/2009	4:09PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/03/2009	4:09PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/03/2009	1:26PM	Business Wire	Eastbourne Capital Sends Letter to Amylin Pharmaceuticals Board of Directors	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/03/2009	1:14PM	Edgar (US Regulatory)	Proxy Statement - Contested Solicitations (preliminary) (PREC14A)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/03/2009	8:51AM	Dow Jones News	2nd UPDATE: Novo Nordisk Shares Slump On Drug Launch Fears	NASDAQ:AMLN	Amylin Pharmaceuticals Inc.
04/03/2009	6:02AM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/03/2009	6:02AM	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)
04/03/2009	5:05AM	Dow Jones News	UPDATE: Novo Nordisk Shares Slump On Liraglutide Launch Fears	NASDAQ:AMLN	Amylin Pharmaceuticals Inc.
04/02/2009	8:41PM	PR Newswire (US)	Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments	NASDAQ:AMLN	Amylin Pharmaceuticals, Inc. (MM)